VKH
SLNOW

Virtu KCG Holdings’s Soleno Therapeutics, Inc. Series A Warrant SLNOW Stock Holding History

Virtu KCG Holdings’s Portfolio SLNOW Stock Details SLNOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$11K Buy
+12,531
New +$11.5K ﹤0.01% 2775

Other funds holding SLNOW

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu KCG Holdings's SLNOW Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Soleno Therapeutics, Inc. Series A Warrant (SLNOW) in Q2 2017: 12,531 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #2775 among its holdings.

5 funds tracked by Wall St. Rank hold SLNOW as of Q2 2017.

  • Virtu KCG Holdings held 12,531 shares of Soleno Therapeutics, Inc. Series A Warrant worth $11K as of Q2 2017.
  • Soleno Therapeutics, Inc. Series A Warrant was a new Virtu KCG Holdings position in Q2 2017.
  • Soleno Therapeutics, Inc. Series A Warrant made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2775 holding.
  • 5 funds tracked by Wall St. Rank held Soleno Therapeutics, Inc. Series A Warrant as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.